Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CirCe T-DM1
NCT01975142Phase 2Completed
- Sponsor
- Institut Curie
- Start
- Nov 2013
- Primary completion
- Feb 2018
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab emtansine in breast cancer, sponsored by Institut Curie. Started Nov 2013; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01975142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975142.